Elena Verna's reverse trials: Wrong for India?

Elena Verna talks about reverse trials: they sound like a win-win for companies (higher conversions + retention), but I’ve seen this backfire in India. Users feel misled when features they’ve been using suddenly disappear post trial, especially if the free tier isn’t clearly communicated upfront. We tested this at my company for a B2B tool, and while initial signups spiked, churn during the transition was brutal. Is this strategy just wrong for markets like India where pricing sensitivity is high? Or are we implementing it wrong?